(Q46761762)

English

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation

scientific article published on 10 February 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

1 reference

based on heuristic

inferred from title

author name string

Matthew J Price

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

Sarah Endemann

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

Raghava R Gollapudi

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

Rafael Valencia

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

Curtiss T Stinis

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

Justin P Levisay

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

Alissa Ernst

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

Neil S Sawhney

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

Richard A Schatz

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

Paul S Teirstein

10

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

publication date

10 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

29

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

992-1000

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Variability in platelet responsiveness to clopidogrel among 544 individuals.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acut

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Stent thrombosis in randomized clinical trials of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN046

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHN046

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18263931

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46761762&oldid=2130274482"